1. Home
  2. LGND vs INSW Comparison

LGND vs INSW Comparison

Compare LGND & INSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGND
  • INSW
  • Stock Information
  • Founded
  • LGND 1987
  • INSW 1999
  • Country
  • LGND United States
  • INSW United States
  • Employees
  • LGND N/A
  • INSW N/A
  • Industry
  • LGND Biotechnology: Pharmaceutical Preparations
  • INSW Semiconductors
  • Sector
  • LGND Health Care
  • INSW Technology
  • Exchange
  • LGND Nasdaq
  • INSW Nasdaq
  • Market Cap
  • LGND 2.0B
  • INSW 1.8B
  • IPO Year
  • LGND 1992
  • INSW N/A
  • Fundamental
  • Price
  • LGND $122.40
  • INSW $38.03
  • Analyst Decision
  • LGND Strong Buy
  • INSW Buy
  • Analyst Count
  • LGND 8
  • INSW 2
  • Target Price
  • LGND $144.71
  • INSW $52.00
  • AVG Volume (30 Days)
  • LGND 139.7K
  • INSW 730.6K
  • Earning Date
  • LGND 08-05-2025
  • INSW 08-06-2025
  • Dividend Yield
  • LGND N/A
  • INSW 10.47%
  • EPS Growth
  • LGND N/A
  • INSW N/A
  • EPS
  • LGND N/A
  • INSW 6.47
  • Revenue
  • LGND $181,488,000.00
  • INSW $860,606,000.00
  • Revenue This Year
  • LGND $18.41
  • INSW N/A
  • Revenue Next Year
  • LGND $18.87
  • INSW $2.05
  • P/E Ratio
  • LGND N/A
  • INSW $5.90
  • Revenue Growth
  • LGND 53.40
  • INSW N/A
  • 52 Week Low
  • LGND $81.74
  • INSW $27.20
  • 52 Week High
  • LGND $129.90
  • INSW $58.73
  • Technical
  • Relative Strength Index (RSI)
  • LGND 70.36
  • INSW 50.90
  • Support Level
  • LGND $111.72
  • INSW $36.03
  • Resistance Level
  • LGND $115.53
  • INSW $40.75
  • Average True Range (ATR)
  • LGND 3.46
  • INSW 1.32
  • MACD
  • LGND 0.18
  • INSW 0.00
  • Stochastic Oscillator
  • LGND 85.52
  • INSW 47.28

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

About INSW International Seaways Inc.

International Seaways Inc owns and operates a fleet of oceangoing vessels engaged in the transportation of crude oil and petroleum products. The company's vessel operations are organized into two segments: Crude Tankers and Product Carriers. The fleet consists of ULCC, VLCC, Suezmax, Aframax, and Panamax crude tankers, as well as LR1, LR2, and MR product carriers.

Share on Social Networks: